Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

156.11
BATS BZX Real-Time Price
As of 11:34am ET
 -2.88 / -1.81%
Today’s Change
130.09
Today|||52-Week Range
181.81
-3.83%
Year-to-Date
Biotech Stocks Earnings Preview: REGN, LGND, ECYT & More
9:53am / Zacks.com
What to Expect from Hubbell (HUBB) This Earnings Season?
Apr 25 / Zacks.com
How to Trade 5 Biotech Stocks After a Fall -- Plus Jim Cramer's Take
9:12am / TheStreet.com
5 Biotech Stocks to Bet on This Earnings Season
Apr 25 / Zacks.com
Biotech ETFs Sink on Mixed Q1 Results
May 02 / Zacks.com
3 Data Points That Will Likely Define Amgen's First-Quarter Report on April 28
Apr 25 / MotleyFool.com
Aside From 1 Eyesore, Amgen Delivers Another Solid Quarter
May 02 / MotleyFool.com
Celgene (CELG) Q1 Earnings: What's in Store for the Stock?
Apr 25 / Zacks.com
2 Dirt-Cheap Big Pharma Stocks Poised to Beat Biotech's Bad Rap
May 02 / TheStreet.com
Healthcare Q1 Earnings Look Solid: ETFs to Benefit
Apr 25 / Zacks.com
Stock Market News for May 02, 2016
May 02 / Zacks.com
Centene (CNC) Q1 Earnings: Surprise in Store for Stock?
Apr 25 / Zacks.com
The Zacks Analyst Blog Highlights: Amgen, Johnson & Johnson, Pfizer, Mylan and Mallin...
May 02 / Zacks.com
Aetna (AET) Q1 Earnings: Is a Surprise in Store for Stock?
Apr 25 / Zacks.com
Amgen (AMGN) Earnings Report: Q1 2016 Conference Call Transcript
May 02 / TheStreet.com
BioMarin (BMRN) Q1 Earnings: Stock Likely to Beat Estimates
Apr 25 / Zacks.com
3 Drug Stocks Reporting Early Next Week: PFE, MYL, MNK
Apr 29 / Zacks.com
Anthem (ANTM): Stock Poised to Beat on Q1 Earnings
Apr 25 / Zacks.com
Amgen (AMGN) Tops Q1 Earnings & Revenues, Ups View
Apr 29 / Zacks.com
Amgen (AMGN) May Beat Q1 Earnings: Will the Stock Gain?
Apr 25 / Zacks.com
Q1 Earnings Reports Continue the Deluge: AMZN, GILD, AMGN
Apr 28 / Zacks.com
Bristol-Myers (BMY) Q1 Earnings: Can the Stock Surprise?
Apr 22 / Zacks.com
Amgen (AMGN) Beats Q1 Earnings Estimates, Raises 2016 Outlook
Apr 28 / Zacks.com
Vertex (VRTX) to Report Q1 Earnings: Is a Surprise in Store?
Apr 22 / Zacks.com
Trade-Ideas: Amgen (AMGN) Is Today's Post-Market Leader Stock
Apr 28 / TheStreet.com
AbbVie (ABBV) Likely to Beat on Q1 Earnings: Stock to Gain?
Apr 22 / Zacks.com
Amgen (AMGN) Stock Higher in After-Hours Trading on Q1 Beat, Guidance
Apr 28 / TheStreet.com
Glaxo (GSK) Q1 Earnings: What's in Store for the Stock?
Apr 22 / Zacks.com
Celgene Corporation Short-Term, Long-Term Guidance Up. Medium-Term? Not So Much
Apr 28 / MotleyFool.com
Will Currency & Competition Hurt Lilly's (LLY) Q1 Earnings?
Apr 21 / Zacks.com
Will Poor Earnings Bring Down the Market?
Apr 28 / TheStreet.com
Biotech Stock Roundup: Medivation Buyout Rumors Resurface, Synta Up on Merger Deal
Apr 20 / Zacks.com
Aegerion (AEGR): Can the Stock Surprise in Q1 Earnings?
Apr 27 / Zacks.com
Amgen's (AMGN) Phase III Study Results on Nplate Published
Apr 20 / Zacks.com
Aerie (AERI): Can the Stock Pull a Surprise in Q1 Earnings?
Apr 27 / Zacks.com
20 Reasons to Buy Amgen and Never Sell
Apr 20 / MotleyFool.com
4 Biotech Stocks Reporting on Apr 28: AMGN, GILD, ALXN, CELG
Apr 27 / Zacks.com
Britain can build a biotech industry to match its Nobel winners
Apr 19 / FT.com
Biotech Stock Gilead (GILD) Likely to Beat in Q1 Earnings
Apr 26 / Zacks.com
Clouds gather over Novartis as it battles series of setbacks
Apr 18 / FT.com
Stocks Are Mixed as Oil Jumps 3%
Apr 26 / TheStreet.com
Drugmakers race to prescribe preventive migraine remedies
Apr 03 / FT.com
Tony Coles - on a mission to tackle Alzheimer's
Apr 26 / FT.com